Novartis has officially inaugurated the its large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina. The facility is a result of a partnership
AmKor Pharma (AmKor) and Hengdian Group (Hengdian) have entered into a licensing agreement for further development and commercialisation of Neu2000 in China. As per the terms of the
Merck KGaA has reported that it will be holding its first Pharma Forum on February 23, 2010 in Darmstadt. The focus will be on pharmaceutical excipients. Regulatory authorities
Bayer CropScience and GVK Biosciences (GVK BIO) have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search
The Automation Partnership (TAP) has reported that its Advanced Projects Group has successfully collaborated with a major European antibody therapeutics company to deliver a custom automated protein purification
Gilead Sciences and GlaxoSmithKline has announced a licensing agreement to commercialise Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B (HBV) infection in adults in five
Micromet has entered into an agreement for the process development and manufacture of blinatumomab (MT103) with Lonza. As per the agreement, Lonza is expected to manufacture blinatumomab for
Shire has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency for velaglucerase alfa, the company’s enzyme replacement therapy in development, for the treatment of Type
Pharmaceutical Research and Manufacturers of America (PhRMA) has released a new report that US pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or
Roche and the Department of Health of Junta de Andalucia, Spain, have signed an agreement for a co-operation in the Medical Genome Project (MGP). Its a research project
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.